Antibiotic resistance and new antimicrobial strategies: Exploring the problem of antibiotic resistance and the development of new drugs

Authors:
  • RURUDN University
    RUDN University
  • SUSouth Ural State Medical University
    South Ural State Medical University
  • PUPavlov First St. Petersburg State Medical University
    Pavlov First St. Petersburg State Medical University
  • NMNorth-Western State Medical University named after I. I. Mechnikov
    North-Western State Medical University named after I. I. Mechnikov
  • SUSurgut State University
    Surgut State University

Abstract
Antibiotic resistance represents a serious global threat to the effectiveness of antibacterial therapy and public health as a whole, requiring immediate attention from researchers, healthcare professionals, pharmaceutical companies, and governmental organizations. This review provides a detailed analysis of the primary mechanisms of antibiotic resistance, including ef-flux pumps, enzymatic inactivation of antibiotics, changes in cellular targets, and biofilms, which play a key role in protecting bacteria from external influences and contribute to their survival. Alternative strategies for developing new antimicrobial agents aimed at overcoming these mechanisms and preventing further spread of resistance are also discussed. Special emphasis is placed on innovative approaches such as phage therapy, the use of antimicrobial peptides, nanoantibiotics, immune therapy methods, and CRISPR-Cas technologies, which offer new prospects for overcoming resistance. The review examines new drug candidates that require further study of their effectiveness, interactions with bacteria, and the use of biomaterials and nanoparticles for delivery. Possible ways to improve the efficiency of clinical trials of new drugs are analyzed. The importance of attracting private and public funding to support research is emphasized.